Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses

Chronic infection with hepatitis B virus (HBV) increases the risk of developing fibrosis, cirrhosis or hepatocellular carcinoma. Current therapies are limited to type‐I interferons and/or nucleos(t)ide analogues; however, these are only partially effective. The development of novel anti‐HBV agents f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishitsuji, Hironori, Harada, Keisuke, Ujino, Saneyuki, Zhang, Jing, Kohara, Michinori, Sugiyama, Masaya, Mizokami, Masashi, Shimotohno, Kunitada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765299/
https://www.ncbi.nlm.nih.gov/pubmed/29121422
http://dx.doi.org/10.1111/cas.13440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765299/
https://www.ncbi.nlm.nih.gov/pubmed/29121422
http://dx.doi.org/10.1111/cas.13440

Ejemplares similares